Joint Diseases Clinical Trials

Conditions:   Rheumatoid Arthritis;   Inflammation
Interventions :   Drug: placebo;   Drug: NNC 0142-0000-0002;   Drug: NNC 0142-0000-0002;   Drug: NNC 0142-0000-0002;   Drug: NNC 0142-0000-0002;   Drug: NNC 0142-0000-0002;   Drug: NNC 0142-0000-0002;   Drug: NNC 0142-0000-0002;   Drug: NNC 0142-0000-0002;   Drug: NNC 0142-0000-0002;   Drug: NNC 0142-0000-0002;   Drug: NNC 0142-0000-0002;   Drug: NNC 142-0000-0002;   Drug: NNC 0142-0000-0002
Sponsor:   Novo Nordisk
Active, not recruiting - verified July 2011